_id
69130cf0ccc777a4e85d7d31
Ticker
LBRX
Name
LB Pharmaceuticals Inc Common Stock
Exchange
NASDAQ
Address
One Pennsylvania Plaza, New York, NY, United States, 10119
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://lbpharma.us
Description
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Last Close
22.07
Volume
603381
Current Price
20.73
Change
-1.82
Last Updated
2026-01-04T16:21:26.697Z
Image
-
Ipo Date
2025-09-11T00:00:00.000Z
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9875
Sentiment Sources
2
Rating
4.33
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
81000
Gross Profit
-81000
Operating Expenses
5165000
Operating Income
-5246000
Interest Expense
-
Pretax Income
-3556000
Net Income
-3556000
Eps
-0.14055834867182243
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-3475000
Operating Margin
-
Total Other Income Expense Net
1690000
Cash
269744000
Short Term Investments
44735000
Receivables
-
Inventories
-
Total Current Assets
316401000
Property Plant Equipment
3833000
Total Assets
320746000
Payables
2590000
Short Term Debt
730000
Long Term Debt
-
Total Liabilities
10525000
Equity
310221000
Bs_currency_symbol
USD
Depreciation
81000
Change In Working Capital
-97000
Cash From Operations
-3373000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
303732000
Net Change In Cash
255523000
Cf_currency_symbol
USD
PE
-
PB
1.6905702207780906
ROE
-1.1462795877777456
ROA
-1.1086654237309272
FCF
-3373000
Fcf Percent
-
Piotroski FScore
1
Health Score
43
Deep Value Investing Score
2.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
2.5
Value Investing Score
4.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
81000
Quarters > 0 > income Statement > gross Profit
-81000
Quarters > 0 > income Statement > operating Expenses
5165000
Quarters > 0 > income Statement > operating Income
-5246000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-3556000
Quarters > 0 > income Statement > net Income
-3556000
Quarters > 0 > income Statement > eps
-0.14055834867182243
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
25299102
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-3475000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1690000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
269744000
Quarters > 0 > balance Sheet > short Term Investments
44735000
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
316401000
Quarters > 0 > balance Sheet > property Plant Equipment
3833000
Quarters > 0 > balance Sheet > total Assets
320746000
Quarters > 0 > balance Sheet > payables
2590000
Quarters > 0 > balance Sheet > short Term Debt
730000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
10525000
Quarters > 0 > balance Sheet > equity
310221000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3556000
Quarters > 0 > cash Flow > depreciation
81000
Quarters > 0 > cash Flow > change In Working Capital
-97000
Quarters > 0 > cash Flow > cash From Operations
-3373000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
303732000
Quarters > 0 > cash Flow > net Change In Cash
255523000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.14055834867182243
Quarters > 0 > ratios > PB
1.6905702207780906
Quarters > 0 > ratios > ROE
-1.1462795877777456
Quarters > 0 > ratios > ROA
-1.1086654237309272
Quarters > 0 > ratios > FCF
-3373000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
43
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
5539000
Quarters > 1 > income Statement > operating Income
-5539000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-5070000
Quarters > 1 > income Statement > net Income
-5071000
Quarters > 1 > income Statement > eps
-0.2259502956580338
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
22442989
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
171000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
22978000
Quarters > 1 > balance Sheet > short Term Investments
5021000
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
28879000
Quarters > 1 > balance Sheet > property Plant Equipment
4157000
Quarters > 1 > balance Sheet > total Assets
33534000
Quarters > 1 > balance Sheet > payables
2320000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
128088000
Quarters > 1 > balance Sheet > equity
-94554000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-5071000
Quarters > 1 > cash Flow > depreciation
80000
Quarters > 1 > cash Flow > change In Working Capital
-2851000
Quarters > 1 > cash Flow > cash From Operations
-5665000
Quarters > 1 > cash Flow > capital Expenditures
238000
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
7873000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.2259502956580338
Quarters > 1 > ratios > PB
-4.920396408084269
Quarters > 1 > ratios > ROE
5.363072953021554
Quarters > 1 > ratios > ROA
-15.121965766088149
Quarters > 1 > ratios > FCF
-5903000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
27
Quarters > 2 > quarter
2024-09-30
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
5000
Quarters > 2 > income Statement > gross Profit
-5000
Quarters > 2 > income Statement > operating Expenses
16078000
Quarters > 2 > income Statement > operating Income
-16082999
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-14181000
Quarters > 2 > income Statement > net Income
-14181000
Quarters > 2 > income Statement > eps
-0.6318677071044325
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
22442989
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-14175999
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1901999
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-14181000
Quarters > 2 > cash Flow > depreciation
5000
Quarters > 2 > cash Flow > change In Working Capital
-9999000
Quarters > 2 > cash Flow > cash From Operations
-22037000
Quarters > 2 > cash Flow > capital Expenditures
443000
Quarters > 2 > cash Flow > cash From Investing
28874000
Quarters > 2 > cash Flow > cash From Financing
20000
Quarters > 2 > cash Flow > net Change In Cash
6857000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.6318677071044325
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-22480000
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-06-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
26580000
Quarters > 3 > income Statement > operating Income
-26580000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-27696000
Quarters > 3 > income Statement > net Income
-27696000
Quarters > 3 > income Statement > eps
-7.823399523579375
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
3540149
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-27051000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-1116000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
-27696000
Quarters > 3 > cash Flow > depreciation
3000
Quarters > 3 > cash Flow > change In Working Capital
9812000
Quarters > 3 > cash Flow > cash From Operations
-15777000
Quarters > 3 > cash Flow > capital Expenditures
41000
Quarters > 3 > cash Flow > cash From Investing
6886000
Quarters > 3 > cash Flow > cash From Financing
3000
Quarters > 3 > cash Flow > net Change In Cash
-8888000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-7.823399523579375
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-15818000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
40
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
64830000
Annuals > 0 > income Statement > operating Income
-64830000
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-63101000
Annuals > 0 > income Statement > net Income
-63102000
Annuals > 0 > income Statement > eps
-17.82772018090466
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
3539544
Annuals > 0 > income Statement > income Tax Expense
1000
Annuals > 0 > income Statement > EBITDA
-63010000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
1729000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
22978000
Annuals > 0 > balance Sheet > short Term Investments
5021000
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
28879000
Annuals > 0 > balance Sheet > property Plant Equipment
4157000
Annuals > 0 > balance Sheet > total Assets
33534000
Annuals > 0 > balance Sheet > payables
2320000
Annuals > 0 > balance Sheet > short Term Debt
487000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
128088000
Annuals > 0 > balance Sheet > equity
-94554000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-63102000
Annuals > 0 > cash Flow > depreciation
91000
Annuals > 0 > cash Flow > change In Working Capital
3313000
Annuals > 0 > cash Flow > cash From Operations
-53052000
Annuals > 0 > cash Flow > capital Expenditures
769000
Annuals > 0 > cash Flow > cash From Investing
23234000
Annuals > 0 > cash Flow > cash From Financing
38315000
Annuals > 0 > cash Flow > net Change In Cash
8497000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-17.82772018090466
Annuals > 0 > ratios > PB
-0.7651530274763628
Annuals > 0 > ratios > ROE
66.73646805000317
Annuals > 0 > ratios > ROA
-188.17319735194133
Annuals > 0 > ratios > FCF
-53821000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
11376000
Annuals > 1 > income Statement > operating Income
-11376000
Annuals > 1 > income Statement > interest Expense
4825000
Annuals > 1 > income Statement > pretax Income
-6274000
Annuals > 1 > income Statement > net Income
-6275000
Annuals > 1 > income Statement > eps
-1.7722218974325519
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
3540753
Annuals > 1 > income Statement > income Tax Expense
1000
Annuals > 1 > income Statement > EBITDA
-1445000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
5102000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
14979000
Annuals > 1 > balance Sheet > short Term Investments
28312000
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
45634000
Annuals > 1 > balance Sheet > property Plant Equipment
23000
Annuals > 1 > balance Sheet > total Assets
45657000
Annuals > 1 > balance Sheet > payables
1389000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
80130000
Annuals > 1 > balance Sheet > equity
-34473000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-6275000
Annuals > 1 > cash Flow > depreciation
4000
Annuals > 1 > cash Flow > change In Working Capital
-1313000
Annuals > 1 > cash Flow > cash From Operations
-12094000
Annuals > 1 > cash Flow > capital Expenditures
25000
Annuals > 1 > cash Flow > cash From Investing
-28010000
Annuals > 1 > cash Flow > cash From Financing
33679000
Annuals > 1 > cash Flow > net Change In Cash
-6425000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.7722218974325519
Annuals > 1 > ratios > PB
-2.0994108815594816
Annuals > 1 > ratios > ROE
18.202651350332143
Annuals > 1 > ratios > ROA
-13.743785180804696
Annuals > 1 > ratios > FCF
-12119000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
28
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
2809000
Annuals > 2 > income Statement > operating Income
-2809000
Annuals > 2 > income Statement > interest Expense
2151000
Annuals > 2 > income Statement > pretax Income
-14347000
Annuals > 2 > income Statement > net Income
-14348000
Annuals > 2 > income Statement > eps
-4.052245383962112
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3540753
Annuals > 2 > income Statement > income Tax Expense
1000
Annuals > 2 > income Statement > EBITDA
-12194000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-11538000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
21404000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
21489000
Annuals > 2 > balance Sheet > property Plant Equipment
3000
Annuals > 2 > balance Sheet > total Assets
21492000
Annuals > 2 > balance Sheet > payables
156000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
24148000
Annuals > 2 > balance Sheet > total Liabilities
50304000
Annuals > 2 > balance Sheet > equity
-28812000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-14348000
Annuals > 2 > cash Flow > depreciation
2000
Annuals > 2 > cash Flow > change In Working Capital
86000
Annuals > 2 > cash Flow > cash From Operations
-2728000
Annuals > 2 > cash Flow > capital Expenditures
0
Annuals > 2 > cash Flow > cash From Investing
123000
Annuals > 2 > cash Flow > cash From Financing
22962000
Annuals > 2 > cash Flow > net Change In Cash
20357000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-4.052245383962112
Annuals > 2 > ratios > PB
-2.5119044606413996
Annuals > 2 > ratios > ROE
49.79869498819936
Annuals > 2 > ratios > ROA
-66.75972454866927
Annuals > 2 > ratios > FCF
-2728000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
31
Valuation > metrics > PE
-0.14055834867182243
Valuation > metrics > PB
1.6905702207780906
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-1.1462795877777456
Profitability > metrics > ROA
-1.1238902531913615
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.03392742593183569
Risk > metrics > Interest Coverage
-64.76543209876543
Risk > final Score
-199
Risk > verdict
High
Liquidity > metrics > Current Ratio
95.30150602409638
Liquidity > metrics > Quick Ratio
95.30150602409638
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
26
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
-100
Prev Risks > 1
-12834
Prev Risks > 2
-135
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:07:35.027Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.58
Earnings History > 0 > eps Difference
0.58
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-06
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.61
Earnings History > 1 > eps Estimate
-0.28
Earnings History > 1 > eps Difference
-0.33
Earnings History > 1 > surprise Percent
-117.8571
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-09-03
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-1.44
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-1.44
Earnings History > 2 > surprise Percent
-
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ALB Pharmaceuticals Inc (NASDAQ:LBRX) Receives Average Rating of “Moderate Buy” from Brokerages Defense World
Read more →LB Pharmaceuticals (NASDAQ:LBRX) Trading Down 5.5% - What's Next? MarketBeat
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
1
Buy
2
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of LB Pharmaceuticals Inc Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.58
Date
2025-09-30
EPS Actual
-0.61
EPS Estimate
-0.28
EPS Difference
-0.33
Surprise Percent
-117.8571%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.